Tenon Medical Inc
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
TNON$1.74-0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
(In thousands, except per share data)
| Years Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Revenue | $2,928 | $691 |
| Cost of sales | 1,687 | 1,332 |
| Gross Profit (Loss) | 1,241 | (641) |
| Operating Expenses | ||
| Research and development | 3,163 | 2,828 |
| Sales and marketing | 6,778 | 7,833 |
| General and administrative | 7,027 | 7,423 |
| Total Operating Expenses | 16,968 | 18,084 |
| Loss from Operations | (15,727) | (18,725) |
| Other Income (Expense) | ||
| Gain on investments | 167 | 180 |
| Interest expense | (21) | (354) |
| Other expense, net | — | (18) |
| Total Other Income (Expense), net | 146 | (192) |
| Net Loss | $(15,581) | $(18,917) |
| Net Loss Per Share of Common Stock | ||
| Basic and diluted | $(8.59) | $(23.62) |
| Weighted-Average Shares of Common Stock Outstanding | ||
| Basic and diluted | 1,814 | 801 |
| Consolidated Statements of Comprehensive Loss: | ||
| Net loss | $(15,581) | $(18,917) |
| Unrealized loss on investments | 16 | (16) |
| Foreign currency translation adjustment | 38 | 7 |
| Total Comprehensive Loss | $(15,527) | $(18,926) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.